{"nct_id":"NCT02991859","title":"Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects","status":"COMPLETED","status_verified_date":"2020-07","start_date":"2017-02-09","start_date_type":"ACTUAL","primary_completion_date":"2018-12-20","primary_completion_date_type":"ACTUAL","completion_date":"2018-12-20","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}